Leading haemostasis diagnostics products

Medirox develops, manufactures and markets reagents, controls and calibrators for improved efficiency in haemostasis diagnostics.

 

Medirox produces high quality control plasmas and diagnostic reagents such as PT, APTT, AT, TT, Fib Clauss and D-Dimer within the field of haemostasis.

Facilities

 
R & D

A true innovation centre
 
Production

High coordination for the highest quality
 
Marketing

Building up a global network

Team

The Medirox team consists of experienced managers, scientists, technicians and regulatory resources who will support you in the best way they possibly can. We continually push innovation within our industry and apply the latest insights in our efforts.

Rikard Rodén

CEO Studsvik

Anna Gimlander

CFO Adminstrator of HR and Finance, Studsvik

Magdalena Tharaldsen, MSc

Director of Business Development, Europe Sales & Marketing, Stockholm

Paula Kiiveri, MSc

Key Account Manager Sales & Marketing, Stockholm

Caroline Enell

Marketing Coordinator Sales & Marketing, Stockholm

Eva Göhl, MSc

R&D Manager R&D, Linköping

Martina Abelius, PhD

Research & Development Scientist R&D, Linköping

Sara Helander, PhD

Research & Development Scientist R&D, Linköping

Linda Östling, BSc

QA/QC Manager QC, Studsvik

Tommy Larsson, MSc

Laboratory Engineer QC QC, Studsvik

Susanne Svensson

Laboratory Technichian QC QC, Studsvik

Eva Håkansson

Laboratory Technician QC QC, Studsvik

Johan Gelin

Site Manager Production, Studsvik

Christer Hultman

Facility and Production Technician Production, Studsvik

Bitte Hedlund

Production Engineer Production, Studsvik

Carina Esseus

Production Engineer Production, Studsvik

Irene Klasson

Production Engineer Production, Studsvik

Liza Sandström

Production Engineer Production, Studsvik

Tove Forsberg

Production Engineer Production, Studsvik

Åsa Andersson

Production Engineer Production, Studsvik
 

Haemostasis

Haemostasis is how the flow of blood in our vessels is kept in balance.
 

History

Medirox was founded in 1998 out of a strong Nordic tradition of coagulation research at Linköpings University hospital. Today the company employees some 20 people and have business world-wide.